Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Atenas
- Development stage
- Discontinued
- Lead developer
- EMS
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
**Atenas** is an oral fixed-dose combination product being developed by **EMS** for patients with **type 2 diabetes mellitus and hypertension**. Public trial records identify Atenas as the combination of **empagliflozin, telmisartan, and amlodipine** in a Phase III randomized, double-blind, triple-dummy study. Mechanistically, it combines an **SGLT2 inhibitor** to lower glucose via increased urinary glucose excretion with an **angiotensin II type 1 receptor blocker** and a **dihydropyridine calcium channel blocker** to reduce blood pressure. The asset appears to be positioned as a single-pill oral cardiometabolic combination intended for patients who require treatment of both hyperglycemia and hypertension.
- Brand names
- Atenas
- Other names
- Atenasempagliflozin + telmisartan + amlodipine
02
Targets
AGTR1 (Angiotensin II Type-1 receptor)SGLT2 (Sodium-glucose cotransporter protein subunit 2)CACNA1C (Voltage-dependent L-type calcium channel subunit alpha-1C)
Beyond the preview
Go deeper on Atenas.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Atenas.